The Nomination Committee consists of:
Laurent Leksell , in his capacity as Chairman of theBoard of Elekta and representing his own and related parties’ holdings- Thomas Wuolikainen, appointed by the
Fourth Swedish National Pension Fund Katarina Hammar , appointed by Nordea Funds- Patrik Jönsson, appointed by SEB Funds
- Jesper Bergström, appointed by Handelsbanken Funds
The Nomination Committee will appoint one of its members as Chairman.
The Nomination Committee is to present proposals for resolutions by the 2024 Annual General Meeting of Shareholders in relation to the following: Chairman of the Annual General Meeting of Shareholders; Chairman of the Board of Directors and other members of the Board of Directors; fees to the Board of Directors; external auditor and fees to the auditor; and where deemed necessary, proposal to amend the procedure for the Nomination Committee.
Shareholders wishing to submit proposals to Elekta’s Nomination Committee can do so by e-mail to valberedningen@elekta.com or by letter to:
Att: Nomination Committee
Box 7593
SE-103 93 Stockholm
In order for the Nomination Committee to be able to process any proposals constructively, these should be received by the Committee no later than
# # #
For further information, please contact:
Tel: +46 76 611 7625, e-mail: cecilia.ketels@elekta.com
Time zone: CET: Central European Time
About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,500 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in
© Modular Finance, source